Press release
FDA Advisory Panel Unanimously Recommends Approval of EXCOR Pediatric Ventricular Assist Device For Use In The United States
At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial. The specific charge of the panel was to review the clinical data from the trial and to make recommendations to the FDA concerning the safety and probable benefit of the EXCOR® VAD as it pertains to an application for Humanitarian Device Exemption (HDE) approval. This 22 member panel was comprised of a group of experts in pediatric and adult cardiology, pediatric and adult cardiac surgery, neurology, biostatistics, and other areas of expertise. It also included patient, consumer, and industry representatives. The panel was chaired by Dr. Clyde Yancy, Chief of the Division of Cardiology at Northwestern University School of Medicine in Chicago, Illinois.
In preparation for presenting the study results to the panel, a team representing Berlin Heart and the investigation was assembled. Working together over several months, including several face to face meetings, this group, now affectionately termed the Berlin Heart “Dream Team”, worked very hard to be well prepared. The main presentation and the bulk of the clinical data and trail results was presented to the Panel by the National Principal Investigator of the study, Charles D. Fraser, Jr., M.D., FACS, Surgeon-in-Chief, Clayton Chair in Surgery, Donovan Chair and Chief, Congenital Heart Surgery, Texas Children's Hospital and Professor of Surgery and Pediatrics, Baylor College of Medicine and Charles E. Canter, M.D. Medical Director, Heart Failure/Transplant Program / St. Louis Children's Hospital, and Professor of Pediatrics, Washington University School of Medicine. Dr. Fraser and Dr. Canter were supported by Rebecca Ichord, M.D., Lori Jordan, M.D., James Tweddell, M.D., David Rosenthal, M.D., Robert Jaquiss, M.D., Peter Wearden, M.D., Elaine Cox, M.D., Patti Massicotte, M.D., Tilman Humpl, M.D., David Naftel, PhD., and Chris Almond, M.D. Supporting the Investigators and Advisors from Berlin Heart were Bob Kroslowitz, VP Clinical Affairs, Mary Beth Kepler, VP Regulatory Affairs and Quality Assurance, and Christine Tjossem Director of Statistical Operations.
The events of the day culminated in the public forum vote by the panel on the questions of EXCOR® device safety and probable benefit. In a thrilling process, the panel members voted unanimously in favor of HDE approval. The commentary from each panel member proved insightful and supportive. This was an emotional and very gratifying experience for all of those in attendance.
Dr. Fraser commented, “This is an enormous step forward for children with heart failure. I would like to personally thank all of the individuals who have been so supportive of this difficult and important study; people from across the United States, Canada and from Germany. We have all worked together to establish a new precedent for our patients.“
The following US centers participated in the IDE study:
- Arkansas Children’s Hospital (AR)
- Boston Children’s Hospital (MA)
- Children’s Healthcare of Atlanta (GA)
- Children’s Hospital of Wisconsin (WI)
- The Children’s Hospital of Denver (CO)
- Lucille Packard Children’s Hospital at Stanford (CA)
- Mott Children’s Hospital (MI)
- Mount Sinai Hospital (NY)
- Pittsburgh Children’s Hospital (PA)
- Riley Children’s Hospital (IN)
- Seattle Children’s Hospital (WA)
- St. Louis Children’s Hospital (MO)
- Texas Children’s Hospital (TX)
- Children’s Hospital at the University of Alabama (AL)
- University of Minnesota at Fairview (MN)
Dr. Stefan Thamasett, CEO of the Berlin Heart Group commented “The Panel’s unanimous decision represents another major milestone for the Berlin Heart Group in bringing this important lifesaving technology to the pediatric population. Completing this historical, first ever prospective controlled clinical trail for Ventricular Assist Devices in children is a major achievement for both Berlin Heart and the Medical Community.”
While Berlin Heart awaits the final decision of the FDA, Implants of the Berlin Heart EXCOR® Pediatric Ventricular Assist Device in the US for BTT patients are continuing under a Continued Access Protocol approved by the FDA.
About Berlin Heart:
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes
implantable and external ventricular assist devices for patients of every age and body size.
The company offers pumps, cannulae, and external components for internal and external use to stabilize cardiac activity in acutely ill patients. Its products are market leaders in their respective segments in Germany and in Europe.
The company also manufactures the implantable left ventricular assist device INCOR®, which has been designed for long-term application in adult patients. The longest the device has supported a patient so far is more than five years and ongoing. INCOR® is not FDA-approved, but widely used in Europe.
Berlin Heart Inc., the company’s US subsidiary, was founded in 2005 to support the North American centers. Further product information is available from the company website:
www.berlinheart.com.
Berlin Heart Inc.
Robert Kroslowitz
200 Valleywood
Suite A500
The Woodlands, TX 77380
kroslowitz@berlinheart.com
Berlin Heart GmbH
Kerstin Unkel
Marketing & PR
Wiesenweg 10
12247 Berlin
unkel@berlinheart.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FDA Advisory Panel Unanimously Recommends Approval of EXCOR Pediatric Ventricular Assist Device For Use In The United States here
News-ID: 185145 • Views: …
More Releases from Berlin Heart
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed.
The clinics in Spain benefit from an excellent service by Palex Medical…
The 1,500th child supported by the Berlin Heart ventricular assist device has be …
The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives.
In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had…
More Releases for Children
Children Bookcases Market Size Analysis by Application, Type, and Region: Foreca …
According to Market Research Intellect, the global Children Bookcases market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The children bookcases market is experiencing steady growth, fueled by increased emphasis on early childhood education and the…
Children Furniture Market is Booming Worldwide with Delta Children, Storkcraft, …
HTF MI just released the Global Children Furniture Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Children Furniture Market are:
IKEA, Delta Children, Storkcraft, KidKraft,…
2 Pakistani Children Honored Globally on the United Nations World Children Day i …
Rockville, MD - Nov 20, 2024 - During the observance of the World Children's Day 2024 across the globe, two Pakistani children have been honoured by the UK-KAKHTAH over their symbolic move of writing an open letter with their own blood to various world bodies about the plight of children in Gaza and other parts of the world.
According to the details issued by the institution, 10-and-a half years old Ubaydah…
N95 Children Masks Market
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Xanthohumol Supplement in global, regional level and country…
Basis Bay contributes to Business Times’ Children for Children Fundraising Eve …
Kuala Lumpur/Singapore 31 October 2019: Basis Bay, a leading provider of Sustainable Cloud and IT Infrastructure Services, remains true to its corporate philosophy of responsiveness to social issues. Recently, Basis Bay contributed to the annual Children for Children (CFC) fundraising and outreach event held in conjunction with Children’s Day in Singapore.
The event saw 1,000 underprivileged children from over 50 schools across Singapore who were brought together for a fun-filled…
Learning Spanish with children
A Spanish language school in Valencia organizes during Eastern holidays Spanish courses for parents and their children
Valencia. The upcoming Eastern holidays offer the whole family the chance to learn the Spanish language. A Spanish school in the centre of Valencia offers the perfect combination for a family holiday: language training for parents and introductory Spanish for children.
The parents attend an intensive Spanish course to learn in a short time as…
